Navigation Links
Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Date:11/12/2009

NEW BRUNSWICK, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT) announced today that Catherine Taylor, one of the Company's funded researchers, will be presenting pre-clinical stability and biological activity data on SNS-01, Senesco's multiple myeloma drug candidate, at the 2009 American Association for Cancer Research (AACR)-National Cancer Institute (NCI)-European Organization for Research and Treatment of Cancer (EORTC) Molecular Targets and Cancer Therapeutics Conference. Ms. Taylor is a member of the Department of Biology at the University of Waterloo, Ontario, Canada. The conference will take place from Sunday, November 15th through Thursday, November 19th, in Boston, MA. Ms. Taylor's abstract will be presented at a session entitled, "Gene Therapies", which will run from 12:30 PM until 2:30 PM on Monday, November 16th.

The conference, hosted by AACR, NCI and EORTC, will bring together academics and scientists and representatives from the pharmaceutical industry to discuss innovation in drug development, target selection and the impact of new discoveries in molecular and cell biology. The event has been organized to reflect the many recent advances in the early development of promising new compounds, which are in different levels of preclinical and clinical development.

About Senesco Technologies, Inc.

Senesco Technologies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. Senesco takes
'/>"/>

SOURCE Senesco Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Senesco Announces H1N1 Influenza Survival Test Results in Mice
2. Senesco Chooses VGXI to Produce Factor 5A Plasmid
3. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
4. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
5. Senesco Technologies Initiates Preclinical Studies for Cancer Target
6. Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting
7. Dr. Brad Vince, with Vince and Associates Clinical Research, Presents at the Exploratory Development World Congress 2009
8. Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration
9. Dr. Julian Henley MD Presents BioMatrix Lift
10. Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology
11. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 27, 2015 RnRMarketResearch.com adds ... research report to its store. This report p ... pipeline. The report "Corneal Ulcers - Pipeline Review, ... development for Corneal Ulcers. Corneal Ulcers are primarily ... infections, viral infections & fungal infections. The symptoms ...
(Date:2/26/2015)... ITASCA, Ill. , Feb. 26, 2015  Today ... paper, The psychological and physical side effects ... belief that opioid painkillers, such as Vicodin and Oxycontin, ... "More Americans overdose on prescription painkillers than on ... , president and CEO of NSC. "Yet, these medications ...
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
... , CINCINNATI , Jan. 28, 2010 The Procter ... of six percent for the October - December quarter to $21.0 ... of the Company,s guidance range.  Diluted net earnings per share were ... $1.01 .  Core EPS increased 22 percent to $1.10 ...
... SEATTLE , Jan. 28 Omeros Corporation (Nasdaq: ... Drug Abuse (NIDA) is providing support for the Company,s Addiction ... a Phase 2 clinical study to be conducted by ... program, Omeros is developing proprietary compositions that include peroxisome proliferator-activated ...
Cached Medicine Technology:P&G Reports Accelerated Sales and Unit Volume Growth 2P&G Reports Accelerated Sales and Unit Volume Growth 3P&G Reports Accelerated Sales and Unit Volume Growth 4P&G Reports Accelerated Sales and Unit Volume Growth 5P&G Reports Accelerated Sales and Unit Volume Growth 6P&G Reports Accelerated Sales and Unit Volume Growth 7P&G Reports Accelerated Sales and Unit Volume Growth 8P&G Reports Accelerated Sales and Unit Volume Growth 9P&G Reports Accelerated Sales and Unit Volume Growth 10P&G Reports Accelerated Sales and Unit Volume Growth 11P&G Reports Accelerated Sales and Unit Volume Growth 12P&G Reports Accelerated Sales and Unit Volume Growth 13P&G Reports Accelerated Sales and Unit Volume Growth 14P&G Reports Accelerated Sales and Unit Volume Growth 15P&G Reports Accelerated Sales and Unit Volume Growth 16P&G Reports Accelerated Sales and Unit Volume Growth 17P&G Reports Accelerated Sales and Unit Volume Growth 18P&G Reports Accelerated Sales and Unit Volume Growth 19P&G Reports Accelerated Sales and Unit Volume Growth 20P&G Reports Accelerated Sales and Unit Volume Growth 21P&G Reports Accelerated Sales and Unit Volume Growth 22P&G Reports Accelerated Sales and Unit Volume Growth 23P&G Reports Accelerated Sales and Unit Volume Growth 24P&G Reports Accelerated Sales and Unit Volume Growth 25P&G Reports Accelerated Sales and Unit Volume Growth 26P&G Reports Accelerated Sales and Unit Volume Growth 27P&G Reports Accelerated Sales and Unit Volume Growth 28P&G Reports Accelerated Sales and Unit Volume Growth 29Omeros Announces National Institute on Drug Abuse's Support for Phase 2 Clinical Study in Addiction Program 2Omeros Announces National Institute on Drug Abuse's Support for Phase 2 Clinical Study in Addiction Program 3Omeros Announces National Institute on Drug Abuse's Support for Phase 2 Clinical Study in Addiction Program 4
(Date:2/28/2015)... 2015 In recent years Medical Marijuana has ... physicians as a way for them to expand their patient ... as medicine. Since the FDA still lists Cannabis as a ... to licensed physicians that can help guide them when ... Malka in Santa Cruz, CA is a leader in ...
(Date:2/28/2015)... With their commitment to achieving physical results ... exercise to their already robust library of oblique exercises. ... known as, is often performed on a stationary piece ... a relatively safe manner and can be performed by ... description of “Rope Pulls” is located in the oblique ...
(Date:2/28/2015)... Mew and Company, a Vancouver corporate tax ... business consulting services in addition to a variety of ... succession planning. Company finances are a complicated matter that ... of this, complex Canadian tax laws can make it ... result, Mew and Company works to advise their clients ...
(Date:2/28/2015)... For those people who are unable to ... Applied Research Foundation (Meso Foundation) will broadcast its ... at 9:30 AM. , The live broadcast is free ... be accessed through any browser on a computer or ... is a unique event that covers important treatment information ...
(Date:2/28/2015)... Dr. Perry Patel , a ... recently announced a special offer for the Zoom!® Chairside ... for new and established patients at his Pismo Beach dentist office. ... white smile, Dr. Patel and his staff are offering ... from the regular price of $450. , Zoom! whitening ...
Breaking Medicine News(10 mins):Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2
... are better. A study of a tropical wasp suggests ... , University of Washington researchers have found that key processing ... one wasp species not only increased in size with age ... also showed different patterns of brain development in males and ...
... Holmes,Inc. (Amex: HH ) today announced that it ... before market on Friday, March 14, 2008.,The Company will ... at,11:00am EDT., Conference Call, To participate in ... code: Hooper Holmes. A live web cast will be ...
... growth, has shown promising results as a potential therapeutic ... its inhibition led to increased muscle mass and strength. ... inhibitor in patients, assessed its safety in adults with ... study was published today in Annals of Neurology ( ...
... County to house world class research, center in country,s Indianapolis region, ... medicine into mainstream ... practice, ... joined by Indiana Gov. Mitch Daniels, broke,ground today on its $140 million ...
... YORK, March 11 HMS Holdings Corp.,(Nasdaq: HMSY ... Bank Of America,2008 SmidCap Conference, which will be held ... Walter Hosp, Chief Financial Officer of HMS Holdings Corp., ... HMS Holdings Corp. (Nasdaq: HMSY ) is ...
... aggravate existing problems, ... CEOs say, ... to reject a proposal to,eliminate the state,s planning process for new hospitals, ... in,funding to care for the elderly and poor, and already grappling with,serious ...
Cached Medicine News:Health News:Which came first, social dominance or big brains? Wasps may tell 2Health News:Which came first, social dominance or big brains? Wasps may tell 3Health News:Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information 2Health News:New potential treatment for muscular dystrophy appears to be safe 2Health News:Medco Breaks Ground For World's Largest Automated Pharmacy 2Health News:Medco Breaks Ground For World's Largest Automated Pharmacy 3Health News:Medco Breaks Ground For World's Largest Automated Pharmacy 4Health News:Medco Breaks Ground For World's Largest Automated Pharmacy 5Health News:Hospital Leaders Urge Legislators Not to Further Destabilize Florida's Healthcare Landscape 2Health News:Hospital Leaders Urge Legislators Not to Further Destabilize Florida's Healthcare Landscape 3
For the quantitative in vitro determination of Potassium in serum or plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
For the quantitative in vitro determination of Valproic Acid in human serum...
For the quantitative in vitro determination of Microalbumin in human urine....
Medicine Products: